China National Pharmaceutical Group Co., Ltd.: 2025 Annual Performance Express Report

2026-03-20 23:10:04

Securities Daily Online News: On March 17, Guoyao Yizhi announced its 2025 performance forecast, stating that the company is expected to achieve a total operating revenue of 73,415,858,400 yuan in 2025, a decrease of 1.29% year-on-year; net profit attributable to shareholders of the listed company is 1,135,926,800 yuan, a year-on-year increase of 76.80%.

(Editor: Ren Shibi)

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes